Home and Office Blood Pressure Monitoring in Renal Transplant Recipients

Table 3

Patients characteristics classified by threshold of BP normality by measurement methods (AH: arterial hypertension).

	Uncontrolled AH	Masked AH	White-coat AH	Controlled AH	P
Age	55.30±12.65	50.87±15.08	50.93±13.66	39.81±10.82	0.002
Body mass index	26.61±0.99	24.25±1.18	24.13±1.18	24.05±1.03	0.23
Sex (male gender, %)	61%	50%	75%	81%	0.19
Delay	4,8±4.4	5.12±6.6	6.0±6.1	7.3±8.3	0.62
HbA1c	6.34±0.18	5.91±0.22	5.61±0.22	5.59±0.65	0.03
HbA1c > 6.5% in treated patients	30%	6%	0%	5%	0.009
Total cholesterol	4.96±1.17	4.86±1.10	4.78±0.64	4.58±0.79	0.61
Triglycerides	1.64±0.62	1.92±0.97	1.94±1.62	1.46±0.63	0.39
LDL cholesterol	2.53±0.60	2.49±0.82	2.63±0.42	2.36±0.85	0.71
C2 cyclosporine	796±146	673±260	586±24	580±213	0.28
C0 tacrolimus	7.3±0.6	8.4±0.7	7.6±0.7	7.7±0.6	0.69
BP treatment (Yes)	96%	80%	87%	67%	0.06